A detailed history of Northern Trust Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Northern Trust Corp holds 3,481,875 shares of TEVA stock, worth $60.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,481,875
Previous 3,537,284 1.57%
Holding current value
$60.9 Million
Previous $49.9 Million 13.36%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $708,127 - $964,116
-55,409 Reduced 1.57%
3,481,875 $56.6 Million
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $533,905 - $722,048
-50,038 Reduced 1.39%
3,537,284 $49.9 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $3.17 Million - $4.15 Million
-390,254 Reduced 9.81%
3,587,322 $37.5 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $1.47 Million - $2.1 Million
195,973 Added 5.18%
3,977,576 $40.6 Million
Q2 2023

Aug 11, 2023

SELL
$7.2 - $9.47 $1.72 Million - $2.27 Million
-239,225 Reduced 5.95%
3,781,603 $28.5 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $1.67 Million - $2.27 Million
-199,494 Reduced 4.73%
4,020,828 $35.6 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $302,664 - $360,913
38,071 Added 0.91%
4,220,322 $38.5 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $469,649 - $818,120
68,462 Added 1.66%
4,182,251 $33.8 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $115,902 - $163,332
15,705 Added 0.38%
4,113,789 $30.9 Million
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $1.31 Million - $1.68 Million
-178,401 Reduced 4.17%
4,098,084 $38.5 Million
Q4 2021

Feb 08, 2022

BUY
$7.9 - $10.19 $90,218 - $116,369
11,420 Added 0.27%
4,276,485 $34.3 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $9.04 Million - $11 Million
-1,079,195 Reduced 20.19%
4,265,065 $41.5 Million
Q2 2021

Aug 13, 2021

SELL
$9.9 - $11.56 $807,919 - $943,388
-81,608 Reduced 1.5%
5,344,260 $52.9 Million
Q1 2021

May 12, 2021

SELL
$10.34 - $12.81 $25.5 Million - $31.5 Million
-2,461,369 Reduced 31.21%
5,425,868 $62.6 Million
Q4 2020

Feb 11, 2021

SELL
$8.61 - $11.04 $587,348 - $753,115
-68,217 Reduced 0.86%
7,887,237 $76.1 Million
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $604,810 - $895,571
-70,573 Reduced 0.88%
7,955,454 $71.7 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $66,218 - $106,993
8,155 Added 0.1%
8,026,027 $99 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $1.83 Million - $3.68 Million
273,850 Added 3.54%
8,017,872 $72 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $450,792 - $740,044
69,034 Added 0.9%
7,744,022 $75.9 Million
Q3 2019

Nov 13, 2019

BUY
$6.16 - $9.6 $400,264 - $623,788
64,978 Added 0.85%
7,674,988 $52.8 Million
Q2 2019

Aug 13, 2019

BUY
$8.12 - $15.72 $6.87 Million - $13.3 Million
846,650 Added 12.52%
7,610,010 $70.2 Million
Q1 2019

May 13, 2019

BUY
$15.58 - $20.01 $1.18 Million - $1.51 Million
75,596 Added 1.13%
6,763,360 $106 Million
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $2.56 Million - $4.18 Million
175,173 Added 2.69%
6,687,764 $103 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $4.49 Million - $5.46 Million
213,000 Added 3.38%
6,512,591 $140 Million
Q2 2018

Sep 18, 2018

SELL
$16.77 - $24.71 $1.09 Million - $1.61 Million
-65,151 Reduced 1.02%
6,299,591 $153 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $10.9 Million - $16 Million
648,590 Added 11.35%
6,364,742 $155 Million
Q1 2018

May 09, 2018

SELL
$16.68 - $22.07 $2.88 Million - $3.82 Million
-172,950 Reduced 2.94%
5,716,152 $97.7 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $2.26 Million - $3.84 Million
-200,992 Reduced 3.3%
5,889,102 $112 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $93.8 Million - $196 Million
6,090,094
6,090,094 $107 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.